Cronos Group Inc. (CRON.TO)
| Previous close | 3.9000 |
| Open | 3.9500 |
| Bid | 3.8000 x 0 |
| Ask | 3.8100 x 0 |
| Day's range | 3.7900 - 4.0000 |
| 52-week range | 2.1450 - 4.0900 |
| Volume | |
| Avg. volume | 258,626 |
| Market cap | 1.49B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1900 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.84 |
Insider MonkeyCronos Group Inc. (NASDAQ:CRON) Q1 2024 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON) Q1 2024 Earnings Call Transcript May 9, 2024 Cronos Group Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Britney Morgan, and I will be your conference operator today. I would […]
- GuruFocus.com
Cronos Group Inc (CRON) Surpasses Analyst Revenue Forecasts in Q1 2024
Record Net Revenue Achieved Amidst Strategic Shifts and Market Expansion
GlobeNewswireCronos Group Reports 2024 First Quarter Results
Industry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year to $25.3 million Spinach® was top-3 in retail sales in Canada in the flower, edible, and vape categories in Q1 2024 Launched PEACE NATURALS® brand in the United Kingdom in May 2024 TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announces its 2024 first quarter business results. “Cronos achie
